Selling Clinical Trials & Research
Clinical Trials & Research
Clinical trials and research are the backbone of medical innovation. Companies in this space are attractive to investors and larger healthcare organizations due to their crucial role in bringing new treatments to market.
Frequently Asked Questions
How are Clinical Trials and Research Companies are Valued?
There are number of valuation methods that can be used in determining the valuation of your company. The most common is based on the top line revenue, bottom line adjusted EBITDA and a multiplier based on market conditions. To get a free and confidential valuation of your company, fill out the form, and one our managing directors will be able to provide you a current market valuation for your company.
How long will it take for me to sell my Clinical trials and research to a potential buyer or an investor?
It is generally a 4-6 month process from the time we receive all the information we need from you to go to market.
Who are the typical buyers for clinical trials and research companies?
Larger pharmaceutical companies, private equity firms, and healthcare organizations.
What are the challenges in selling a clinical trials business?
Ensuring regulatory compliance and maintaining relationships with sponsors during the transition.
What factors determine the value of a clinical trials or research company?
Valuation is influenced by the types of trials conducted, client contracts, and regulatory compliance.
